الصفحة 1
الصفحة 1
Multi-dimensional Approaches Towards New Technology : Insights on Innovation, Patents and Competition
This open access edited book captures the complexities and conflicts arising at the interface of intellectual property rights (IPR) and competition law. To do so, it discusses four specific themes: (a) policies governing functioning of standard setting organizations (SSOs), transparency and incentivising future innovation; (b) issue of royalties for standard essential patents (SEPs) and related disputes; (c) due process principles, procedural fairness and best practices in competition law; and (d) coherence of patent policies and consonance with competition law to support innovation in new technologies.
Molecular Marker Systems in Plant Breeding and Crop Improvement
Successful release of new and better crop varieties increasingly requires genomics and molecular biology. This volume presents basic information on plant molecular marker techniques from marker location up to gene cloning. The text includes a description of technical approaches in genome analysis such as comparison of marker systems, positional cloning, and array techniques in 19 crop plants. A special section focuses on converting this knowledge into general and specific breeding strategies, particularly in relation to biotic stress. Theory and practice of marker assisted selection for QTL, gene pyramiding and the future of MAS are summarized and discussed for maize, wheat, and soybean. Furthermore, approaches in silviculture on the examples of Fagus, Populus, Eucalyptus, Picea and Abies are presented. The volume ends with a comprehensive review of the patents relevant for using molecular markers and marker assisted selection.
Intellectual Property Management in R&D Collaborations : The Case of the Service Industry Sector
This book of about two hundred and seventy pages examines the complex and challenging problem of how companies can take an intellectual property lead within research and development (R&D) collaborations. … He compiled a typology for managing intellectual property in R&D collaborations.The findings of the book are based on a series of interviews with companies in a variety of industries and regions, as well as on a detailed examination of the service companies IBM, SAP, Swisscom and SwissRe.
Intellectual Property in the Food Technology Industry : Protecting Your Innovation
Considering the effort and funding devoted to a company's success, understanding Intellectual Property rights patents, trade secrets, trademarks, and licensing is essential. Establishing appropriate internal policies from the outset can prevent companies from learning a costly and painful lesson in the courtroom. With Intellectual Property in the Food Technology Industry, currently the only book of its kind focusing specifically on the food industry, one will learn what to consider throughout the various creative phases of a product's lifespan from initial research and development initiatives through post-production.
Innovation, Industrial Dynamics and Structural Transformation : Schumpeterian Legacies
This book provides an account of work in the Schumpeterian and evolutionary tradition of industrial dynamics and the evolution of industries. It is shown that over time industries evolve and change their structure. In this dynamic process change is affected and sometimes constraint by many factors: knowledge and technologies, the capabilities and incentives of actors, new products and processes, and institutions. All these elements and their relations drive innovative activities and affect economic performance in an industry. Investigations into these complex phenomena show a deep interdependence between empirical work delivering a rich account of regularities and stylized facts in the structure of industries and their change, and theoretical analyses ranging from appreciate theorizing to formal modeling.
Innovation, Economic Development, and Intellectual Property in India and China : Comparing Six Economic Sectors
This book analyses intellectual property and innovation governance in the development of six key industries in India and China. These industries are reflective of the innovation and economic development of the two economies, or of vital importance to them: the IT Industry, the film industry, the pharmaceutical industry, plant varieties and food security, the automobile industry, and the sharing economy. The analysis extends beyond the domain of IP law, and includes economics and policy analysis. The overarching concerns of the book are how the examined industries have developed in the two countries, what role state innovation policy and/or IP policy has played in such development, what the nature of the state innovation policy/IP policy is, whether such policy has been causal, facilitating, crippling, co-relational, or simply irrelevant, and whether there is a possibility of synergy between the two economies. The book also inquires as to why and how one specific industry has developed in one country and not in the other, and what India and China can learn from each other.
Indiscrete Thoughts
Indiscrete Thoughts gives a glimpse into a world that has seldom been described, that of science and technology as seen through the eyes of a mathematician. The era covered by this book, 1950 to 1990, was surely one of the golden ages of science as well as of the American university. Cherished myths are debunked along the way as Gian-Carlo Rota takes pleasure in portraying, warts and all, some of the great scientific personalities of the period —Stanislav Ulam (who, together with Edward Teller, signed the patent application for the hydrogen bomb), Solomon Lefschetz (Chairman in the 1950s of the Princeton mathematics department), William Feller (one of the founders of modern probability theory), Jack Schwartz (one of the founders of computer science), and many others.
Handbook of quantitative science and technology research : The use of publication and patent statistics in studies of S&T systems
This handbook offers a state-of-the-art overview of quantitative science and technology research. It focuses on the development and application of indicators derived from data on scientific or scholarly publications and patents. It comprises 34 chapters written by leading specialists in the various sub-domains. These chapters deal with theoretical and methodological issues, illustrate applications, and highlight their policy context and relevance. Authors present a survey of the research topics they address, and show their most recent achievements.
Handbook of pharmaceutical manufacturing formulations ; Vol.6 : Sterile products
An authoritative and practical guide to the art and science of formulating drugs for commercial manufacturing. With thoroughly revised and expanded content, this six-volume set compiles data from FDA new drug applications, patent applications, and other sources of generic and proprietary formulations to cover the broad spectrum of GMP formulations and issues in using these formulations in a commercial setting. A must-have collection for pharmaceutical manufacturers, educational institutions, and regulatory authorities, this is an excellent platform for drug companies to benchmark their products and for generic companies to formulate drugs coming off patent
Handbook of pharmaceutical manufacturing formulations ; Vol.5 : Over-the-counter products
An authoritative and practical guide to the art and science of formulating drugs for commercial manufacturing. With thoroughly revised and expanded content, this six-volume set compiles data from FDA new drug applications, patent applications, and other sources of generic and proprietary formulations to cover the broad spectrum of GMP formulations and issues in using these formulations in a commercial setting. A must-have collection for pharmaceutical manufacturers, educational institutions, and regulatory authorities, this is an excellent platform for drug companies to benchmark their products and for generic companies to formulate drugs coming off patent
Handbook of pharmaceutical manufacturing formulations ; Vol.4 : Semisolid products
An authoritative and practical guide to the art and science of formulating drugs for commercial manufacturing. With thoroughly revised and expanded content, this six-volume set compiles data from FDA new drug applications, patent applications, and other sources of generic and proprietary formulations to cover the broad spectrum of GMP formulations and issues in using these formulations in a commercial setting. A must-have collection for pharmaceutical manufacturers, educational institutions, and regulatory authorities, this is an excellent platform for drug companies to benchmark their products and for generic companies to formulate drugs coming off patent
Handbook of pharmaceutical manufacturing formulations ; Vol.3 : Liquid products
An authoritative and practical guide to the art and science of formulating drugs for commercial manufacturing. With thoroughly revised and expanded content, this six-volume set compiles data from FDA new drug applications, patent applications, and other sources of generic and proprietary formulations to cover the broad spectrum of GMP formulations and issues in using these formulations in a commercial setting. A must-have collection for pharmaceutical manufacturers, educational institutions, and regulatory authorities, this is an excellent platform for drug companies to benchmark their products and for generic companies to formulate drugs coming off patent
Handbook of pharmaceutical manufacturing formulations ; Vo.1 : Compressed solid products
An authoritative and practical guide to the art and science of formulating drugs for commercial manufacturing. With thoroughly revised and expanded content, this first volume of a six-volume set, compiles data from FDA new drug applications, patent applications, and other sources of generic and proprietary formulations to cover the broad spectrum of GMP formulations and issues in using these formulations in a commercial setting. A must-have collection for pharmaceutical manufacturers, educational institutions, and regulatory authorities, this is an excellent platform for drug companies to benchmark their products and for generic companies to formulate drugs coming off patent
Global Lessons from the AIDS Pandemic : Economic, Financial, Legal and Political Implications
This book examines the global HIV/AIDS pandemic from a multidisciplinary perspective, analyzing its economic impact, the reasons behind the political response to the pandemic, international laws relating to public health and patents and mechanisms for financing global and national responses. The authors paint a global picture of the HIV/AIDS pandemic one issue, one country and one region at a time and show why prevention, treatment and human rights protection must each form part of a comprehensive HIV/AIDS strategy. The book analyzes the successes and failures of national governments, international organizations and the private sector in fighting the HIV/AIDS pandemic and recommends changes to our international economic, financial, legal and political institutions. This book highlights the lessons the world has to learn from our experience with HIV/AIDS in order to improve the way we address global diseases.
Genetic programming IV : Routine human-competitive machine intelligence
Genetic Programming IV: Routine Human-Competitive Machine Intelligence presents the application of GP to a wide variety of problems involving automated synthesis of controllers, circuits, antennas, genetic networks, and metabolic pathways. The book describes fifteen instances where GP has created an entity that either infringes or duplicates the functionality of a previously patented 20th-century invention, six instances where it has done the same with respect to post-2000 patented inventions, two instances where GP has created a patentable new invention, and thirteen other human-competitive results. The book additionally establishes: GP now delivers routine human-competitive machine intelligence GP is an automated invention machine GP can create general solutions to problems in the form of parameterized topologies GP has delivered qualitatively more substantial results in synchrony with the relentless iteration of Moore's Law
Frontiers in Anti-Infective Drug Discovery ; Vol.9
Covers a range of topics including rational drug design and drug discovery, medicinal chemistry, in-silico drug design, combinatorial chemistry, high-throughput screening, drug targets, recent important patents, and structure-activity relationships. Frontiers in Anti-Infective Drug Discovery is a valuable resource for pharmaceutical scientists and post-graduate students seeking updated and critically important information for developing clinical trials and devising research plans in this field. The ninth volume of this series features 5 reviews that cover some aspects of clinical and pre-clinical antimicrobial drug development, with 2 chapters focusing on drugs to treat leishmaniasis and dengue fever, respectively. - Use of preclinical and early clinical data for accelerating antimicrobial drug development - Post-translational modifications: host defence mechanism, pathogenic weapon, and emerged target of anti-infective drugs - Scope and limitations on the potent antimicrobial activities of hydrazone derivatives - Current scenario of anti-leishmanial drugs and treatment - Dengue hemorrhagic fever: the potential repurposing drugs
From research to market : A comprehensive guide
A vital resource for anyone involved in the journey from academia to commercialization. It outlines the main stages and key milestones of technology transfer in a clear and engaging manner, featuring real-world examples of successful university research outcomes. Analyse the circumstances behind their success and learn the essential steps for a successful technology transfer process. Designed as a go-to reference for researchers, doctoral and master's students, scientific entrepreneurs, and academics focused on innovation and entrepreneurship, this book is also invaluable for technology managers at universities, research centres, and public agencies. Enhance your understanding of technology transfer and gain practical knowledge to navigate this complex field successfully.
Forecasting Innovations : Methods for Predicting Numbers of Patent Filings
This is a practical guide to solutions for a case study of forecasting demand for services and products in international markets - and so much more than just another listing of dry theoretical methods. Leading experts present studies on improvements to methods for forecasting numbers of incoming patent filings at the European Patent Office. Studies are presented from econometric, survey and systems theory viewpoints.
Filoviruses : A Compendium of 40 Years of Epidemiological, Clinical, and Laboratory Studies
This book summarizes in detail the contemporary knowledge of filoviruses and diseases they cause. Almost the entirety of the open literature on filoviruses, covering all major scientific and clinical fields, is referenced and summarized in this text, including most of the conference abstracts, book chapters, dissertations, government reports, patents, theses, and journal publications in many languages.
Encyclopedia of Genetics, Genomics, Proteomics and Informatics
It includes about 56% more words than the 1,392-page 2nd edition of 2003. The number of illustrations increased to almost 2,000 and their quality has improved by design and four colors. Cross-references among entries are expanded. The statements are supported by references; more than 14,000 journal papers and more than 3,000 books are listed. The book includes ~1,800 current databases and web servers. Retractions and corrigenda are pointed out.It covers the basics and the latest in genomics, proteomics, genetic engineering, small RNAs, transcription factories, chromosome territories, stem cells, genetic networks, epigenetics, prions, hereditary diseases, patents, etc. Similar integrated information is not available in textbooks or on the Internet. The journal reviews called it the best, high-quality resource for researchers, instructors and students of basic and applied biology, as well as for physicians and lawyers or even for interested laymen because of the clarity of presentation.
